Cargando…
The budgetary impact of alemtuzumab in multiple sclerosis in Quito, Ecuador. Payer’s perspective
INTRODUCTION: Multiple sclerosis is a neurological condition that causes disabilities and is most common in young adults. It imposes high financial costs affecting the quality of life of patients, families, and society. It is critical to measure the budgetary impact of new technologies to treat this...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AboutScience
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616185/ https://www.ncbi.nlm.nih.gov/pubmed/36627868 http://dx.doi.org/10.33393/grhta.2021.2273 |